Targeting LAG-3 to Potentiate Antitumor Immune Activity: Expert Guidance on Molecular Function and Clinical Application

This series of live workshops will cover the importance of LAG-3 as a new immunotherapy target and the emerging data on the mechanism of action use and safety of anti&ndash LAG-3 immunotherapies across a range of malignancies. Accompanying these workshops will be a downloadable slideset simulcasts an expert commentary a PDF practice resource and an on-demand webcast.

Live webinars!

Webinar 1 - June 28 2022

Webinar 2 - July 6 2022

Webinar 3 - July 19 2022

 

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Bristol Myers Squibb